FFA
XBI icon

Fragasso Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Fragasso Financial Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$439K Buy
2,772
+3
+0.1% +$406 0.02% 234
2026
Q1 		$357K Hold
2,769
– – 0.02% 240
2025
Q4 		$338K Buy
2,769
+8
+0.3% +$917 0.02% 234
2025
Q3 		$286K Buy
2,761
+1
+0% +$90 0.02% 244
2025
Q2 		$229K Hold
2,760
– – 0.02% 261
2025
Q1 		$224K Buy
2,760
+1
+0% +$89 0.02% 245
2024
Q4 		$249K Hold
2,759
– – 0.02% 233
2024
Q3 		$273K Sell
2,759
-41
-1% -$4.03K 0.02% 219
2024
Q2 		$260K Buy
2,800
+2
+0.1% +$179 0.02% 228
2024
Q1 		$266K Hold
2,798
– – 0.02% 222
2023
Q4 		$250K Sell
2,798
-284
-9% -$21.1K 0.02% 222
2023
Q3 		$225K Hold
3,082
– – 0.02% 211
2023
Q2 		$256K Buy
3,082
+41
+1% +$3.43K 0.03% 205
2023
Q1 		$232K Hold
3,041
– – 0.03% 198
2022
Q4 		$252K Buy
+3,041
New +$246K 0.03% 182

Other funds holding XBI

MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

Fragasso Financial Advisors's XBI Position: Q2 2026 in Review

Fragasso Financial Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.11% in Q2 2026, buying an estimated $406 and bringing the position to 2,772 shares worth $439K. The position accounts for 0.02% of the portfolio, ranked #234.

Fragasso Financial Advisors first reported a position in XBI in Q4 2022 and has held it in 15 quarters since. 350 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Fragasso Financial Advisors held 2,772 shares of State Street SPDR S&P Biotech ETF worth $439K as of Q2 2026.
  • Fragasso Financial Advisors bought 3 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $406.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Fragasso Financial Advisors's portfolio in Q2 2026, its #234 holding.
  • Fragasso Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 15 quarters since.
  • 350 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Fragasso Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.